Algert Global’s Cardiovascular Systems, Inc. CSII Stock Holding History

Algert Global’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-16,844	Closed	-$335K	–	1334
2023 Q1	$335K	Sell	16,844 -95,107	-85%	-$1.64M	0.02%	921
2022 Q4	$1.52M	Sell	111,951 -23,040	-17%	-$321K	0.08%	397
2022 Q3	$1.87M	Buy	134,991 +15,367	+13%	+$228K	0.11%	287
2022 Q2	$1.72M	Buy	119,624 +12,750	+12%	+$221K	0.13%	245
2022 Q1	$2.42M	Buy	106,874 +46,215	+76%	+$897K	0.16%	172
2021 Q4	$1.14M	Buy	60,659 +12,360	+26%	+$330K	0.14%	238
2021 Q3	$1.59M	Buy	48,299 +33,779	+233%	+$1.26M	0.21%	99
2021 Q2	$619K	Buy	14,520 +3,270	+29%	+$128K	0.21%	154
2021 Q1	$431K	Buy	+11,250	New	+$479K	0.14%	232

Other funds holding CSII

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Algert Global's CSII Position: Q2 2023 in Review

Algert Global sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 16,844 shares — an estimated $335K sold.

Algert Global first reported a position in CSII in Q1 2021 and held it in 9 quarters. The position peaked at $2.42M in Q1 2022. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

Algert Global reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
Algert Global sold 16,844 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $335K.
Algert Global first reported a position in Cardiovascular Systems, Inc. in Q1 2021 and held it in 9 quarters.
Algert Global's Cardiovascular Systems, Inc. position peaked at $2.42M in Q1 2022.
2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Algert Global's 13F filing for Q2 2023, filed 14 Aug 2023.